CC
BLFS icon

Casdin Capital’s BioLife Solutions BLFS Stock Holding History

Casdin Capital’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$114M Hold
5,957,165
– – 8.61% 4
2025
Q4 		$144M Sell
5,957,165
-750,000
-11% -$19.6M 8.95% 3
2025
Q3 		$171M Sell
6,707,165
-1,000,000
-13% -$23.7M 14.27% 2
2025
Q2 		$166M Sell
7,707,165
-1,000,000
-11% -$22.5M 15.12% 2
2025
Q1 		$199M Hold
8,707,165
– – 16.25% 2
2024
Q4 		$226M Hold
8,707,165
– – 15.04% 2
2024
Q3 		$218M Hold
8,707,165
– – 14.54% 1
2024
Q2 		$187M Hold
8,707,165
– – 14.25% 1
2024
Q1 		$162M Hold
8,707,165
– – 12.01% 3
2023
Q4 		$141M Buy
8,707,165
+927,165
+12% +$11.8M 13.89% 2
2023
Q3 		$107M Buy
7,780,000
+58,465
+0.8% +$921K 11.89% 2
2023
Q2 		$171M Buy
7,721,535
+150,000
+2% +$3.16M 14.91% 1
2023
Q1 		$165M Buy
7,571,535
+5,243
+0.1% +$118K 13.57% 1
2022
Q4 		$138M Hold
7,566,292
– – 10.67% 2
2022
Q3 		$172M Hold
7,566,292
– – 11.31% 2
2022
Q2 		$104M Hold
7,566,292
– – 8.83% 3
2022
Q1 		$172M Hold
7,566,292
– – 7.71% 1
2021
Q4 		$282M Hold
7,566,292
– – 7.95% 1
2021
Q3 		$320M Buy
7,566,292
+126,185
+2% +$6.08M 7.97% 2
2021
Q2 		$331M Hold
7,440,107
– – 8.41% 2
2021
Q1 		$268M Hold
7,440,107
– – 7.98% 4
2020
Q4 		$297M Buy
7,440,107
+1,600,000
+27% +$54.6M 8.79% 2
2020
Q3 		$169M Buy
5,840,107
+990,583
+20% +$21.4M 7.57% 2
2020
Q2 		$79.3M Buy
4,849,524
+2,380,953
+96% +$32.8M 4.69% 7
2020
Q1 		$23.5M Hold
2,468,571
– – 2.49% 16
2019
Q4 		$39.9M Buy
2,468,571
+40,000
+2% +$650K 3.67% 12
2019
Q3 		$40.4M Hold
2,428,571
– – 4.18% 10
2019
Q2 		$39.4M Hold
2,428,571
– – 3.69% 12
2019
Q1 		$43.4M Hold
2,428,571
– – 4.77% 9
2018
Q4 		$29.2M Hold
2,428,571
– – 5% 9
2018
Q3 		$42.5M Buy
2,428,571
+1,428,571
+143% +$28.3M 5.17% 6
2018
Q2 		$11.4M Buy
+1,000,000
New +$9.1M 1.6% 21

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Casdin Capital's BLFS Position: Q1 2026 in Review

Casdin Capital held its BioLife Solutions (BLFS) position steady in Q1 2026 at 5,957,165 shares worth $114M. The position accounts for 8.61% of the portfolio, ranked #4.

Casdin Capital first reported a position in BLFS in Q2 2018 and has held it in 32 quarters since. The position peaked at $331M in Q2 2021. 187 funds tracked by Wall St. Rank hold BLFS as of Q1 2026.

  • Casdin Capital held 5,957,165 shares of BioLife Solutions worth $114M as of Q1 2026.
  • Casdin Capital left its BioLife Solutions share count unchanged in Q1 2026.
  • BioLife Solutions made up 8.61% of Casdin Capital's portfolio in Q1 2026, its #4 holding.
  • Casdin Capital first reported a position in BioLife Solutions in Q2 2018 and has held it in 32 quarters since.
  • Casdin Capital's BioLife Solutions position peaked at $331M in Q2 2021.
  • 187 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2026.

Based on Casdin Capital's 13F filing for Q1 2026, filed 15 May 2026.